Clarius Group LLC’s Zimmer Biomet ZBH Stock Holding History

Clarius Group LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,808	Closed	-$263K	–	514
2023 Q2	$263K	Buy	1,808 +19	+1%	+$2.58K	0.02%	428
2023 Q1	$231K	Buy	1,789 +203	+13%	+$25.5K	0.02%	451
2022 Q4	$202K	Buy	+1,586	New	+$184K	0.02%	482
2022 Q2	–	Sell	-1,750	Closed	-$222K	–	529
2022 Q1	$222K	Sell	1,750 -53	-3%	-$6.39K	0.02%	449
2021 Q4	$222K	Buy	1,803 +380	+27%	+$49.7K	0.02%	449
2021 Q3	$202K	Buy	1,423 +27	+2%	+$3.97K	0.02%	406
2021 Q2	$218K	Buy	1,396 +2	+0.1%	+$324	0.02%	378
2021 Q1	$217K	Sell	1,394 -11	-0.8%	-$1.7K	0.02%	348
2020 Q4	$210K	Buy	+1,405	New	+$198K	0.02%	325

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clarius Group LLC's ZBH Position: Q3 2023 in Review

Clarius Group LLC sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,808 shares — an estimated $263K sold.

Clarius Group LLC first reported a position in ZBH in Q4 2020 and held it in 9 quarters. The position peaked at $263K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Clarius Group LLC reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Clarius Group LLC sold 1,808 Zimmer Biomet shares in Q3 2023, an estimated $263K.
Clarius Group LLC first reported a position in Zimmer Biomet in Q4 2020 and held it in 9 quarters.
Clarius Group LLC's Zimmer Biomet position peaked at $263K in Q2 2023.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Clarius Group LLC's 13F filing for Q3 2023, filed 19 Oct 2023.